Cita APA (7a ed.)

L, Z., K, Z., H, Z., J, Z., Y, P., Z, W., . . . B, W. (2019). Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Dove Medical Press.

Cita Chicago Style (17a ed.)

L, Zhang, Zhu K, Zeng H, Zhang J, Pu Y, Wang Z, Zhang T, y Wang B. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.

Cita MLA (8a ed.)

L, Zhang, et al. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.